During a recent meeting at the American Cancer Executives Meeting in Charleston, South Carolina, I had the opportunity to listen to Bill Laffey speak on the CoC standards. His perspective from being an administrator rather than a physician was a change from most presentations I had heard. I went on to ask him a few questions I thought would be of interest to our readers. …
Consultant Spotlight: Erica Sabatini, CTR
Erica serves as a QC manager and Project manager for Registry Partners Incorporated. As a QC manager, she performs weekly quality control reviews on all her assigned projects in addition to providing guidance and support to the project CTRs in answering abstracting questions. Erica has been instrumental in project set up and defining the abstracting parameters of new projects. Recently, Erica began to mentor a on-site registrar…
“Where are my patients going?” and other questions you don’t know you already have the answers to
We Have the Questions, YOUR Cancer Registry Has the Answers! With the depth and the quality of the cancer registry data collection process within cancer programs, it is hard not to ask questions related to your patient population and why your program is growing or in some cases not growing? Listed below is a very small example in a world full of thousands and thousands of…
Q&A: SEER Summary Stage 2000 Category
Q: A patient is diagnosed with Lung cancer with findings positive of left supraclavicular lymph node metastasis. The lung tumor is located in the LUL with no further extension noted. What is the SEER Summary Stage? A: Per SEER General Summary Stage manual, involvement of supraclavicular lymph nodes, ipsilateral or contralateral is a code 7 – Distant.